D-GLUCOSE (U-13C6, 99%), MICROBIOLOGICAL/PYROGEN TESTED
ID: NIMH24003242Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

All Other Basic Organic Chemical Manufacturing (325199)

PSC

QUALITY CONTROL- CHEMICALS AND CHEMICAL PRODUCTS (H168)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/0db85913b9b54d0abb4dc1f769973bb6/view
Timeline
    Description

    Sources Sought HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking a Total Small Business Set-Aside for the procurement of U-13C glucose. U-13C glucose is typically used in clinical research to study brain metabolism in healthy volunteers. The glucose will be prepared into a 20% solution for oral administration, with each human study requiring 40-50 grams of U-13C glucose depending on the subject's body weight. The procurement will take place in Andover, MA, USA. For more information, contact Joe Kennedy at joseph.kennedy@nih.gov or 2623917630.

    Point(s) of Contact
    Joseph Kennedy
    joseph.kennedy@nih.gov
    Robin Knightly
    Robin.knightly@nih.gov
    Lifecycle
    Title
    Type
    D-GLUCOSE (U-13C6, 99%), MICROBIOLOGICAL/PYROGEN TESTED
    Currently viewing
    Combined Synopsis/Solicitation
    Purchase U-13C glucose for human study
    Sources Sought
    Similar Opportunities
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Center for Advancing Translational Sciences (NCATS), is seeking qualified small businesses to provide Chemistry, Manufacturing, and Controls (CMC) and related services for the development of drug products. The objective of this procurement is to support the Therapeutic Development Branch in ensuring the delivery of drug products of sufficient quality and quantity for preclinical, IND-enabling, and clinical studies, which are critical for advancing therapeutic candidates through the drug development pipeline. This opportunity is part of a Small Business Sources Sought notice, aimed at gathering information on the capabilities of small businesses to fulfill these requirements, with a focus on compliance with applicable regulations and the potential for a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract. Interested vendors must submit their capability statements by 10:00 AM Eastern Time on July 21, 2024, to Michelle Cecilia at michelle.cecilia@nih.gov.
    Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract for reagents and consumables to STEMCELL Technologies Inc. for use with the RoboSep™-S Cell Separator Systems at the NIH Clinical Center in Bethesda, Maryland. The procurement includes specific items such as the EasySep HLA Chimerism WB Myeloid Positive Selection kit, the EasySep HLA Chimerism WB CD3 Positive Selection kit, and RoboSep Filter Tip Racks, which are critical for separating cell populations in allogeneic transplant patients to assess engraftment status. Interested vendors capable of providing equivalent products may submit a capability statement by the specified deadline, with inquiries directed to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov. The acquisition falls under NAICS code 325414, and the total purchase order will not exceed the simplified acquisition threshold.
    Qiagen LLC Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a firm fixed-price contract to Qiagen LLC for the procurement of reagent kits and consumables essential for isolating DNA and RNA from patients' blood samples. The reagents are critical for conducting tests related to hematological disorders and stem cell transplants, supporting both clinical care and research initiatives within the NIH's Department of Laboratory Medicine. This acquisition is being conducted under the Simplified Acquisition Procedures, allowing for a sole-source procurement due to the unique capabilities of Qiagen LLC's products, which have been fully validated for specific assays. Interested vendors capable of providing similar products are encouraged to submit capability statements to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov by the specified deadline.
    66--Smart-Kage System
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information regarding the procurement of a Smart-Kage System. This opportunity is categorized as a Sources Sought notice, aimed at identifying potential vendors capable of providing this analytical laboratory instrument, which falls under the NAICS code 334516. The Smart-Kage System is crucial for laboratory applications, enhancing research capabilities within the NIH's National Heart, Lung, and Blood Institute (NHLBI). Interested parties are encouraged to reach out to Helmut Winffel at helmut.winffel@nih.gov or call 301-435-0330 for further details and to express their interest in this procurement opportunity.
    Gore Medical branded stents (Brand Name restriction)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, National Institutes of Health seeks to procure specific medical devices for use in interventional radiology procedures. These are brand-restricted items, with the National Institute of Health specifying Gore Medical branded stents. The scope of work involves supplying several variants of two medical devices: Viatorr Tips Endo CX and Viabahn BX Balloon Expander Endo. The Viatorr Tips are measured in millimeters and vary in length, while the Viabahn BX Balloon Expanders are used in catheterization procedures. The medical devices are intended for minimally invasive procedures. The bill of materials provided outlines the exact models and quantities sought. Offerors must provide the following: 1 unit of Model PTB8105275, ID 00733132635016 - 8-10mmX5cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model PTB8107275, ID 00733132635030 - 8-10mmX7cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model PTB8108275, ID 00733132635047 - 8-10mmX8cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model BXB083901A, ID 00733132658718 - 8MMX39MM 7Fr 80CM Cath RP VIABAHN BX BALLOON EXP ENDO 1 unit of Model BXB085901A, ID 00733132658732 - 8MMX59MM 7Fr 80CM Cath RP VIABAHN BX BALLOON EXP ENDO Eligible applicants should be well-established surgical and medical instrument manufacturers (NAICS code 339112) with the ability to deliver the specified devices promptly. The evaluation of quotes will consider technical capability, price, and past performance. Quotes should be submitted to Lu Chang at lu-chang.lu@nih.gov by 5:00 PM EST on 08/01/2024, including the RFQ number (RFQ-CC-24-010258) in the subject line. Further inquiries can be directed to the same email address. This opportunity is a combined synopsis and solicitation issued under FAR Subpart 12.6. The resulting contract will be a firm fixed-price order.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under Request for Proposal (RFP) No. 75N95024R00003. The primary objective of this procurement is to acquire, analyze, create, regulate, and distribute a variety of drug compounds essential for advancing research on drug abuse and addiction, including controlled and uncontrolled substances such as morphine, methadone, and various cannabinoid preparations. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement for a five-year period, is crucial for supporting the drug abuse research community by ensuring the availability of authentic drug products while adhering to federal regulations. Proposals must be submitted electronically by November 15, 2024, and interested parties can contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov for further information.
    Pharmaceutical Preparation Manufacturing
    Active
    Dept Of Defense
    Sources Sought DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is seeking local sources capable and interested in fulfilling a requirement for the procurement and delivery of CLASS VIII, Medical Laboratory Reagents, in support of United States Naval Hospital (USNH), located in Okinawa, Japan. The procurement is for ULTRA TECHNE KOW 18.5GBq Injection Generator, with an estimated quantity of 26 units per year. The delivery location will be the United States Naval Hospital (USNH) Okinawa Nuclear Medicine Department, Camp Foster, Okinawa, Japan. Interested parties should provide company information, capability to provide the items, and item lead times. Responses must be submitted by Thursday, November 09, 2023, via email to jasielle.castro@dla.mil and mamiko.jackson@dla.mil.
    Diabetic Supplies - Santa Fe Indian Health Center
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Indian Health Service (IHS), is seeking qualified Small Business Indian Firms to provide diabetic supplies for the Santa Fe Indian Health Center in New Mexico. The procurement includes a variety of essential diabetic products, such as Accu-Chek test strips, lancets, control solutions, and DCA reagent kits, which are critical for managing diabetes within the community. Interested vendors must respond to this sources sought notice by demonstrating their eligibility as an Indian Economic Enterprise under the Buy Indian Act, providing necessary documentation, and ensuring registration in SAM.gov. For further inquiries, interested parties can contact Patricia P Trujillo at patricia.trujillo@ihs.gov or by phone at 505-256-6754.
    Blanket Purchase Agreement (BPA) for Dry Ice / CO2
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking proposals for a Blanket Purchase Agreement (BPA) to supply dry ice and liquid carbon dioxide (CO2) for its laboratory operations. The procurement aims to secure a reliable source of food-grade dry ice pellets and medical-grade CO2, with specific purity levels and delivery requirements outlined for the Roybal and Lawrenceville campuses. This BPA, valued at an estimated $4.8 million over five years, is set aside for service-disabled veteran-owned small businesses and emphasizes competitive pricing, compliance with federal regulations, and stringent performance guidelines. Interested vendors must submit their quotes electronically by August 20, 2024, and direct any inquiries to James Brown III at xvn8@cdc.gov.
    Synedgen, Inc. - Award Notice
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) has awarded a federal contract to Synedgen, Inc. for the advance development of PAAG17G (DP:MIIST305), a high molecular weight glycopolymer designed as a medical countermeasure to mitigate mortality and morbidity following exposure to lethal ionizing radiation. This contract, valued at $16,937,463, emphasizes the government's commitment to enhancing public health safety in emergency situations, particularly in the context of biodefense and medical innovation. The project will be performed in Claremont, California, with the contract effective from September 26, 2024, and responses to the associated solicitation number BAA-23-100-SOL-00004 due by October 2, 2024. For further inquiries, interested parties may contact Jonathan Gonzalez, the Contracting Officer, at Jonathan.Gonzalez@hhs.gov or (202) 381-7248.